434 related articles for article (PubMed ID: 29559746)
1. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
[TBL] [Abstract][Full Text] [Related]
2. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
[TBL] [Abstract][Full Text] [Related]
3. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
4. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
[TBL] [Abstract][Full Text] [Related]
5. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
6. Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
Eder S; Arndt A; Lamkowski A; Daskalaki W; Rump A; Priller M; Genze F; Wardelmann E; Port M; Steinestel K
Cancer Lett; 2017 Jan; 385():160-167. PubMed ID: 27793696
[TBL] [Abstract][Full Text] [Related]
7. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
[TBL] [Abstract][Full Text] [Related]
8. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
[TBL] [Abstract][Full Text] [Related]
9. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030
[TBL] [Abstract][Full Text] [Related]
10. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
[TBL] [Abstract][Full Text] [Related]
11. DNMT1 maintains the methylation of miR-152-3p to regulate TMSB10 expression, thereby affecting the biological characteristics of colorectal cancer cells.
Wang C; Ma X; Zhang J; Jia X; Huang M
IUBMB Life; 2020 Nov; 72(11):2432-2443. PubMed ID: 32918845
[TBL] [Abstract][Full Text] [Related]
12. Quadruple-editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS-mutated colorectal cancer cells.
Wang Z; Kang B; Gao Q; Huang L; Di J; Fan Y; Yu J; Jiang B; Gao F; Wang D; Sun H; Gu Y; Li J; Su X
Cancer Sci; 2021 Sep; 112(9):3895-3910. PubMed ID: 34185934
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
Hata T; Mokutani Y; Takahashi H; Inoue A; Munakata K; Nagata K; Haraguchi N; Nishimura J; Hata T; Matsuda C; Murata K; Mizushima T; Doki Y; Mori M; Yamamoto H
Int J Oncol; 2017 Feb; 50(2):487-496. PubMed ID: 28000854
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
Li X; Wang J; Zhang C; Lin C; Zhang J; Zhang W; Zhang W; Lu Y; Zheng L; Li X
J Pathol; 2018 Oct; 246(2):166-179. PubMed ID: 29943828
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
Zhang D; Zhao L; Shen Q; Lv Q; Jin M; Ma H; Nie X; Zheng X; Huang S; Zhou P; Wu G; Zhang T
Int J Cancer; 2017 May; 140(10):2298-2309. PubMed ID: 28213952
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
Amankwatia EB; Chakravarty P; Carey FA; Weidlich S; Steele RJ; Munro AJ; Wolf CR; Smith G
Br J Cancer; 2015 Apr; 112(9):1480-90. PubMed ID: 25919696
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
Chen M; Lin M; Wang X
Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of VEGF and PARP suppresses KRAS-mutant colorectal cancer.
Zhong L; Wang R; Wang Y; Peng S; Ma Y; Ding S; Yang H; Chen S; Luo X; Wang W
Neoplasia; 2020 Sep; 22(9):365-375. PubMed ID: 32629177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
